Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis.

Condrat CE, Thompson DC, Barbu MG, Bugnar OL, Boboc A, Cretoiu D, Suciu N, Cretoiu SM, Voinea SC.

Cells. 2020 Jan 23;9(2). pii: E276. doi: 10.3390/cells9020276. Review.

2.

Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview.

Staicu CE, Predescu DV, Rusu CM, Radu BM, Cretoiu D, Suciu N, Crețoiu SM, Voinea SC.

Cells. 2020 Jan 9;9(1). pii: E169. doi: 10.3390/cells9010169. Review.

3.

G Protein-Coupled Receptors (GPCRs)-Mediated Calcium Signaling in Ovarian Cancer: Focus on GPCRs activated by Neurotransmitters and Inflammation-Associated Molecules.

Predescu DV, Crețoiu SM, Crețoiu D, Pavelescu LA, Suciu N, Radu BM, Voinea SC.

Int J Mol Sci. 2019 Nov 7;20(22). pii: E5568. doi: 10.3390/ijms20225568. Review.

4.

Management of Breast Cancer Locoregional Recurrence.

Voinea SC, Sandru A, Blidaru A.

Chirurgia (Bucur). 2017 Jul-Aug;112(4):429-435. doi: 10.21614/chirurgia.112.4.429. Review.

5.

Molecular analysis of BRCA1 and BRCA2 genes by next generation sequencing and ultrastructural aspects of breast tumor tissue.

Mihalcea CE, Moroşanu AM, Murăraşu D, Puiu L, Cinca SA, Voinea SC, Mirancea N.

Rom J Morphol Embryol. 2017;58(2):445-455.

6.

Particular molecular and ultrastructural aspects in invasive mammary carcinoma.

Mihalcea CE, Moroşanu AM, Murăraşu D, Puiu L, Cinca S, Voinea SC, Mirancea N.

Rom J Morphol Embryol. 2015;56(4):1371-81.

Supplemental Content

Loading ...
Support Center